Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)

NCT04330820

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations
  • Klinikum Augsburg, Medizinische Klinik II Augsburg, Germany
  • Klinikum Chemnitz, Krankenhaus Küchwald, Klinik für Innere Medizin III Chemnitz, Germany
  • Universitätsklinikum Dresden, Medizinische Klinik I Dresden, Germany
  • Universitätsklinikum Essen; Zentrum für Innere Medizin Essen, Germany
View Trial Details
Completed

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

NCT02108028

Conditions
Cancer, Chronic Disease, Chronic Granulomatous Disease, +17 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

NCT04008706

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Long Beach, California, United States
  • Research Site Redlands, California, United States
  • Research Site Whittier, California, United States
View all 108 locations
View Trial Details
Completed

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

NCT03157635

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Institut hematologie Centre Hayem CHU paris Saint-Louis Lariboisiere F Widal Hopital St Louis Paris, France
  • Uniklinik RWTH Aachen Aachen, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Ulm Ulm, Germany
View all 15 locations
View Trial Details
Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details

Related conditions